30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

4Q13/2013 Revenue: aap Implantate

2013 revenue:  €40MM (~US $55.1MM), +10%

  • Trauma ~$13.2MM, +52% (LOQTEQ ~$6.8MM, +150%)


  • Signed development/supply agreement for PMMA bone cement & mixing system
  • In early 2014, divested non-core Adcon anti-adhesion product, orthopaedic reconstructive implants (hip, knee, shoulder) and EMCM contract manufacturing business
  • For 2014, seeks to grow Trauma to >€15MM